Showing results (11-20 of 66) with videos related to
Sort By:
Pageof 7
Molecular Medicine (Cambridge, Mass.)|July 14, 2009
Nonerythropoietic tissue protective compounds are highly effective facilitators of wound healingZübeyde Erbayraktar, Serhat Erbayraktar, Osman Yilmaz, et al.Anesthesiology|August 30, 2011
ARA290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain: an experimental study in rats and β-common receptor knockout miceMaarten Swartjes, Aurora Morariu, Marieke Niesters, et al.Expert Opinion on Investigational Drugs|February 22, 2014
ARA 290 for treatment of small fiber neuropathy in sarcoidosisMonique van Velzen, Lara Heij, Marieke Niesters, et al.Brain Research|October 5, 2002
Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitisDavide Agnello, Paolo Bigini, Pia Villa, et al.The Journal of Pharmacology and Experimental Therapeutics|April 16, 2013
Chronic administration of small nonerythropoietic peptide sequence of erythropoietin effectively ameliorates the progression of postmyocardial infarction-dilated cardiomyopathyIsmayil Ahmet, Hyun-Jin Tae, Michael Brines, et al.Proceedings of the National Academy of Sciences of the United States of America|November 9, 2006
Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxiaMonica Fantacci, Paola Bianciardi, Anna Caretti, et al.Journal of Cardiovascular Pharmacology|October 1, 2010
Erythropoietin derivate improves left ventricular systolic performance and attenuates left ventricular remodeling in rats with myocardial infarct-induced heart failureKai Xu, Isaac George, Stefan Klotz, et al.Transplantation|December 20, 2015
A Nonhematopoietic Erythropoietin Analogue, ARA 290, Inhibits Macrophage Activation and Prevents Damage to Transplanted IsletsMasaaki Watanabe, Torbjörn Lundgren, Yu Saito, et al.Proceedings of the National Academy of Sciences of the United States of America|July 28, 2010
Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietinHiroto Ueba, Michael Brines, Michael Yamin, et al.Molecular Pain|February 18, 2014
ARA 290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia responseMaarten Swartjes, Monique van Velzen, Marieke Niesters, et al.Pageof 7